for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Zelta inicia ensayos clínico con compuesto contra dolor ocular

MADRID, 6 jun (Reuters) - Zeltia ZEL.MC dijo el lunes que iniciará ensayos clínicos de fase I con un nuevo compuesto para el tratamiento del dolor asociado al síndrome del ojo seco.

El ensayo con el compuesto, desarrollado por su filial Sylentis, se realizará en voluntarios en la Clínica Universidad de Navarra, dijo la nota de prensa de Zeltia.

Breakingviews

Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.


Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up